Study warns of high Medicare costs for semaglutide even with restrictive CVD definition

If Medicare Part D narrowly defines cardiovascular disease, the majority of patients would remain ineligible while new federal spending could still exceed $10 billion

COVID-19’s unseen impact: study reveals surge in home deaths across 32 countries

Trends in places of death across 32 countries during and before the COVID-19.

January 5, 2024

Use of Home-Based OCT for Neovascular AMD Could Lead to More Timely Treatment

A retrospective review of home-based optical coherence tomography (OCT) monitoring for neovascular age-related macular degeneration (AMD) found that treatment should have been performed earlier in

November 22, 2024

NJ judge tosses Novartis’ IRA lawsuit in another win for government

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.